These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11530127)
1. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Douchi T; Oki T; Yamasaki H; Kuwahata R; Nakae M; Nagata Y Obstet Gynecol; 2001 Sep; 98(3):445-9. PubMed ID: 11530127 [TBL] [Abstract][Full Text] [Related]
2. Serum androgen levels and muscle mass in women with polycystic ovary syndrome. Douchi T; Yamamoto S; Oki T; Maruta K; Kuwahata R; Nagata Y Obstet Gynecol; 1999 Sep; 94(3):337-40. PubMed ID: 10472855 [TBL] [Abstract][Full Text] [Related]
3. Difference in non-weight-bearing effects on bone mineral density between trunk and peripheral fat mass in women with polycystic ovary syndrome. Yanazume Y; Kawamura Y; Kuwahata A; Yonehara Y; Matsuo T; Iwamoto I; Douchi T J Obstet Gynaecol Res; 2010 Apr; 36(2):352-6. PubMed ID: 20492387 [TBL] [Abstract][Full Text] [Related]
4. Relationships among serum testosterone levels, body fat and muscle mass distribution in women with polycystic ovary syndrome. Douchi T; Yoshimitsu N; Nagata Y Endocr J; 2001 Dec; 48(6):685-9. PubMed ID: 11873867 [TBL] [Abstract][Full Text] [Related]
5. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. Yüksel O; Dökmetaş HS; Topcu S; Erselcan T; Sencan M J Bone Miner Metab; 2001; 19(4):257-62. PubMed ID: 11448019 [TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and body composition in lean women with polycystic ovary syndrome. Good C; Tulchinsky M; Mauger D; Demers LM; Legro RS Fertil Steril; 1999 Jul; 72(1):21-5. PubMed ID: 10428143 [TBL] [Abstract][Full Text] [Related]
7. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Kirchengast S; Huber J Hum Reprod; 2001 Jun; 16(6):1255-60. PubMed ID: 11387301 [TBL] [Abstract][Full Text] [Related]
8. Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome. Ganie MA; Chakraborty S; Sehgal A; Sreejith M; Kandasamy D; Jana M; Rashid A Horm Metab Res; 2018 Oct; 50(10):754-760. PubMed ID: 30312986 [TBL] [Abstract][Full Text] [Related]
9. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540 [TBL] [Abstract][Full Text] [Related]
10. Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients. Karadağ C; Yoldemir T; Gogas Yavuz D Gynecol Endocrinol; 2017 Mar; 33(3):234-237. PubMed ID: 27908213 [TBL] [Abstract][Full Text] [Related]
11. Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women. McBreairty LE; Zello GA; Gordon JJ; Serrao SB; Pierson RA; Chizen DR; Chilibeck PD J Clin Densitom; 2018; 21(1):54-60. PubMed ID: 28034591 [TBL] [Abstract][Full Text] [Related]
12. Relationship of upper body fat distribution to higher regional lean mass and bone mineral density. Matsuo T; Douchi T; Nakae M; Uto H; Oki T; Nagata Y J Bone Miner Metab; 2003; 21(3):179-83. PubMed ID: 12720053 [TBL] [Abstract][Full Text] [Related]
13. Relationship of head lean mass to regional bone mineral density in elderly postmenopausal women. Douchi T; Iemura A; Matsuo T; Kuwahata T; Oki T; Yoshimitsu N; Nagata Y Maturitas; 2003 Nov; 46(3):225-30. PubMed ID: 14585526 [TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women. Filip R; Raszewski G Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340 [TBL] [Abstract][Full Text] [Related]
15. Androgens and bone density in women with hypopituitarism. Miller KK; Biller BM; Hier J; Arena E; Klibanski A J Clin Endocrinol Metab; 2002 Jun; 87(6):2770-6. PubMed ID: 12050248 [TBL] [Abstract][Full Text] [Related]
16. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome. Chen MJ; Han DS; Yang JH; Yang YS; Ho HN; Yang WS Hum Reprod; 2012 Aug; 27(8):2476-83. PubMed ID: 22693174 [TBL] [Abstract][Full Text] [Related]
17. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome. Noyan V; Yucel A; Sagsoz N Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356 [TBL] [Abstract][Full Text] [Related]
18. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance. Mario FM; do Amarante F; Toscani MK; Spritzer PM Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259 [TBL] [Abstract][Full Text] [Related]
19. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes. Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477 [TBL] [Abstract][Full Text] [Related]
20. The effect of circulating androgens on bone mineral density in postmenopausal women. Tok EC; Ertunc D; Oz U; Camdeviren H; Ozdemir G; Dilek S Maturitas; 2004 Jul; 48(3):235-42. PubMed ID: 15207889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]